#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Still's disease B-cell small lymphocytic lymphoma Pouchitis Breast angiosarcoma metastatic Hereditary motor and sensory neuropathy Meningitis meningococcal Intracranial germ cell tumour Philadelphia chromosome positive Cystic fibrosis Pelizaeus-Merzbacher disease Metastases to peritoneum Autologous haematopoietic stem cell transplant Extra-osseous Ewing's sarcoma metastatic Pancreatic carcinoma metastatic Sickle cell disease More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Basic Information Sarcoidosis Hereditary motor and sensory neuropathy – Trials in Disease Propionic acidaemia – Basic Information Mantle cell lymphoma – Diagnostics Primary biliary cholangitis – Treatment Methylmalonic acidaemia Arterial tortuosity syndrome – Life with Disease Bronchopulmonary dysplasia – Treatment Optic glioma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Samuraciclib Fitusiran Threonine Enomimeran 534 NVG-2089 Anselamimab Phenylephrine Jab-21822 Festuca Rubra Pollen Magrolimab Medroxyprogesterone Acetate Mk-1167 Fostemsavir CC-97540 IMMUNOSTEM OMECAMTIV MECARBIL Abemaciclib Valine VISUGROMAB More therapies…

    Learn about Your Condition

    Autoimmune disorder Polymyalgia rheumatica Strongyloidiasis Breast cancer female Biliary adenoma Addison's disease Glioblastoma Pleomorphic leiomyosarcoma Hyperhidrosis Normal pressure hydrocephalus Hepatic neoplasm Alpha-1 antitrypsin deficiency Menopausal symptoms Liver disorder Arthroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Psilocybin for Patients with Treatment-Resistant Depression

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    Austria

  • Study on the Effectiveness of Dexamethasone for Reducing Swelling, Pain, and Jaw Stiffness in Patients Undergoing Wisdom Tooth Extraction

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone
    Spain

  • Study on the Effectiveness and Safety of Ultevursen for Patients with Retinitis Pigmentosa Due to USH2A Gene Mutations

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Retinitis pigmentosa
    Investigated Drugs:
    • ULTEVURSEN
    France Germany Italy The Netherlands

  • Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Paraganglion neoplasm
    • Phaeochromocytoma
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    Italy

  • Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Masitinib
    Denmark France Greece Norway Sweden

  • Study on Filgotinib and Triamcinolone for Newly Diagnosed Rheumatoid Arthritis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Triamcinolone Acetonide
    The Netherlands
Previous Page
1 … 806 807 808 809 810 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!